glp-1 drug mounjaro Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with drugs among patients with type 2 diabetes, a large retrospective cohort FDA approves tirzepatide, Eli Lilly's

However, some doctors may prescribe it off - label for women with PCOS, particularly when insulin resistance or weight gain are major concerns

German formulation companies increased production of compliant high-fiber meal replacements tailored to GLP-1 pathways

A comprehensive study of their pleiotropic effects may elucidate their function in addressing the other several facets of metabolic disorder, thereby justifying their high cost by preventing numerous problems

Participants with class III obesity (BMI 40 or higher) were more likely to be late responders, meaning they needed more time to achieve significant weight loss

Small dosing errors can cause serious harm Require therapeutic drug monitoring (TDM) Need careful dose adjustment High risk of adverse drug reactions Drug-drug and drug-food interactions are common Best Practices for Safe Use: Follow the 10 Rights of medication administration Monitor lab values regularly Double-check calculations and doses Educate patients regarding compliance and warning signs Report and analyze medication-related incidents Patient safety begins with medication safety